Clinical trial · Interventional
Healthy Directions After Lung Surgery Pilot
Feasibility and Acceptability of a Lifestyle Intervention for Patients Receiving Surgical Treatment for Lung Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this proposal is to test the feasibility and acceptability of a lifestyle risk reduction intervention for patients with lung cancer receiving surgical treatment. This study will provide the preliminary data needed to conduct a larger randomized controlled trial that tests an innovative, multidisciplinary intervention that has the potential to transform the standard of care for patients receiving surgical treatment for lung cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma, Non Small Cell Lung | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Lifestyle counseling | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Lifestyle counseling
- description
- This is a single arm, quasi-experimental, pre- and post- test study design to test the feasibility and acceptability of a multiple risk factor, lifestyle intervention in patients receiving surgical treatment for lung cancer or those suspected of having lung cancer.
- interventionNames
- Behavioral: Lifestyle counseling
Primary outcomes (4)
- measure
- Feasibility and acceptability
- timeFrame
- at end of study (4 months post intervention)
- description
- The primary outcome measures to establish feasibility and acceptability of the intervention for this study are enrollment rates.
- measure
- Feasibility and acceptability
- timeFrame
- at end of study (4 months post intervention)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Patient Inclusion Criteria: * \> 21 years of age * English speaking * MD approval to participate in study * Meets one of the inclusions below: * 1\. a histological diagnosis of NSCLC undergoing potentially curative treatment * 2\. OR those undergoing surgical procedures for lung cancer (includes patients undergoing diagnostic testing or those presenting with lung nodules * 3.OR patients who have had a surgical procedure for lung cancer within the last six months. * May invite a buddy to join study with them defined as a friend, partner, adult child or sibling Buddy Inclusion Criteria: * ≥ 21 years of age, * English speaking, who is invited by the subject to join as a support person (e.g., friend, partner, adult child or sibling)
References
Publications (0)
Data not yet available